文献速递胃肠外科肝胆胰外科

圆韧带贲门固定术治疗袖状胃切除术后胃食管反流

Ligamentum teres cardiopexy for post vertical sleeve gastrectomy gastroesophageal reflux.
PubMed 文献 · Surg Endosc · 2023-07-05

本研究回顾性分析了2017至2022年间60例既往行袖状胃切除术后药物难治性胃食管反流病患者,接受圆韧带贲门固定术。在完成1年随访的36例患者中,81%的患者抗分泌药物剂量减少或停用。结论认为该术式可作为Roux-en-Y胃旁路术的可行替代方案。

要点

  • 袖状胃切除术后药物难治性GERD可考虑圆韧带贲门固定术。
  • 1年随访中81%患者抗分泌药物剂量减少或停用。
  • 该术式或可替代Roux-en-Y胃旁路术,避免其相关风险。

核心结论

  • 圆韧带贲门固定术是袖状胃切除术后药物难治性GERD患者替代Roux-en-Y胃旁路术的可行选择。

研究设计与样本

  • 回顾性 chart review,纳入2017至2022年间既往行腹腔镜或机器人袖状胃切除术、后续GERD症状对药物治疗难治并接受圆韧带贲门固定术的患者60例。

主要发现

  • 60例患者中位年龄50岁,86%为女性,所有患者术前均诊断为GERD并服用抗分泌药物。
  • 完成1年随访的36例患者中,81%在术后1年抗分泌药物剂量减少或停用。

临床怎么用

  • 对于袖状胃切除术后药物难治性GERD患者,可考虑圆韧带贲门固定术作为Roux-en-Y胃旁路术的替代术式。

局限性

  • 回顾性研究设计,样本量60例,仅36例完成1年随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Vertical sleeve gastrectomy (VSG) evolved in the early 2000s into the standalone weight loss procedure we see today. While numerous studies highlight VSG's durability for weight loss, and improvements co-morbidities such as type 2 diabetes mellitus and cardiovascular disease, patients with gastroesophageal reflux disease (GERD) have been counseled against VSG due to the concern for worsening reflux symptoms. When considering anti-reflux procedures, VSG patients are unable to undergo traditional fundoplication due to lack of gastric cardia redundancy. Magnetic sphincter augmentation lacks long-term safety data and endoscopic approaches have undetermined longitudinal benefits. Until recently, the only option for patients with a history of VSG with medically refractory GERD has been conversion to roux en Y gastric bypass (RNYGB), however, this poses other risks including marginal ulcers, internal hernias, hypoglycemia, dumping syndrome, and nutritional deficiencies. Given the risks associated with conversion to RNYGB, we have adopted the ligamentum teres cardiopexy as an option for patients with intractable GERD following VSG. METHODS: A retrospective chart review was conducted of patients who had prior laparoscopic or robotic VSG and subsequently GERD symptoms refectory to pharmacological management who underwent ligamentum teres cardiopexy between 2017 and 2022. Pre-operative GERD disease burden, intraoperative cardiopexy characteristics, post-operative GERD symptomatology and changes in H2 blocker or PPI requirements were reviewed. RESULTS: Of the study's 60 patients the median age was 50 years old, and 86% were female. All patients had a diagnosis of GERD through pre-operative assessments and were taking antisecretory medication. Of the 36 patients who have completed their one year follow up, 81% of patients had either a decrease in dosage or cessation of the antisecretory medication at one year following ligamentum teres cardiopexy. CONCLUSION: Ligamentum teres cardiopexy is a viable alternative to RNYGB in patients with a prior vertical sleeve gastrectomy with medical refractory GERD.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Mackey EE, Dore FJ, Kelly JF, et al. Ligamentum teres cardiopexy for post vertical sleeve gastrectomy gastroesophageal reflux. Surg Endosc. 2023. PMID: 37407712. doi:10.1007/s00464-023-10239-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。